Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)
Author(s) -
Wojciech Zaręba,
Helmut Klein,
Iwona Cygankiewicz,
William J. Hall,
Scott McNitt,
Mary W. Brown,
David S. Cannom,
James P. Daubert,
Michael Eldar,
Michael R. Gold,
Jeffrey J. Goldberger,
Ilan Goldenberg,
Edgar Lichstein,
Heinz F. Pitschner,
Mayer Rashtian,
Scott D. Solomon,
Sami Viskin,
Paul J. Wang,
Arthur J. Moss
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.110.960898
Subject(s) - medicine , cardiac resynchronization therapy , cardiology , left bundle branch block , ejection fraction , heart failure , qrs complex , clinical endpoint , ventricular tachycardia , implantable cardioverter defibrillator , hazard ratio , ventricular fibrillation , sinus rhythm , atrial fibrillation , randomized controlled trial , confidence interval
This study aimed to determine whether QRS morphology identifies patients who benefit from cardiac resynchronization therapy with a defibrillator (CRT-D) and whether it influences the risk of primary and secondary end points in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) trial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom